Multi-Billion Dollar Opioid Litigation Targets Drug Companies, Drugstores, and Maybe DoctorsThe Motley Fool • 01/08/20
Cardinal (CAH) Up 3.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/07/19
Cardinal Health, Inc. (CAH) CEO Mike Kaufmann on Fiscal Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Cardinal Health Posts a Big Q1 Loss Due to Opioid Litigation but Still Beats EstimatesThe Motley Fool • 11/07/19
Cardinal Health (CAH) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/31/19